Hana Hassanin

University of Surrey - Surrey Clinical Research Centre

MD

Egerton Road

Guildford, Surrey, England GU2 7XP

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

1,570

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against COVID-19: COVAC1, a Phase I, Dose-Ranging Trial

Number of pages: 34 Posted: 16 Jun 2021
Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, University College London - MRC Clinical Trials Unit, NIHR UCLH Clinical Research Facility, Imperial College London, NIHR Imperial Clinical Research Facility, University College London - MRC Clinical Trials Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London, Imperial College London, University College London Hospitals NHS Foundation Trust - Department of Clinical Virology, University College London, Government of the United Kingdom - Chelsea and Westminster Hospital NHS Foundation Trust, Imperial College London, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Surrey - Surrey Clinical Research Centre, St George’s University London - St George’s Vaccine Institute, Imperial College London - Department of Infectious Disease, Imperial College London - Section of Virology, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Imperial College London - Department of Infectious Disease
Downloads 1,535 (23,579)

Abstract:

Loading...

2.

Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults

Number of pages: 120 Posted: 19 Sep 2018
International AIDS Vaccine Initiative, New York, NIHR Imperial Clinical Research Facility, International AIDS Vaccine Initiative, New York, University of Surrey - Surrey Clinical Research Centre, International AIDS Vaccine Initiative, London, Duke University - Department of Surgery, International AIDS Vaccine Initiative, London, International AIDS Vaccine Initiative, New York, The EMMES Corporation, University of Surrey - Surrey Clinical Research Centre, Duke University - Department of Surgery, International AIDS Vaccine Initiative, New York, Global BioSolutions, International AIDS Vaccine Initiative, London, University of Pennsylvania - Children's Hospital of Philadelphia, University of Pennsylvania - Children's Hospital of Philadelphia and University of Pennsylvania - Children's Hospital of Philadelphia
Downloads 35 (834,626)

Abstract:

Loading...